Molecular Characterization of TET2 in Cytogenetically Normal Acute Myeloid Leukemia

被引：0
|
作者：
Lee, J. [1 ,2 ]
Jun, K. [2 ]
Song, S. [2 ]
Oh, S. [1 ]
Shin, J. [1 ]
Kim, H. [1 ]
Lee, J. [1 ,2 ]
机构：
[1] Inje Univ, Busan Paik Hosp, Pusan, South Korea
[2] Haeundae Paik Hosp, Pusan, South Korea
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2013年 / 15卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：858 / 858
页数：1
相关论文
共 50 条
  • [1] TET2 Mutations in Cytogenetically Normal Acute Myeloid Leukemia: Clinical Implications and Evolutionary Patterns
    Damm, Frederik
    Markus, Birgit
    Thol, Felicitas
    Morgan, Michael
    Goehring, Gudrun
    Schlegelberger, Brigitte
    Krauter, Juergen
    Heuser, Michael
    Bernard, Olivier A.
    Ganser, Arnold
    GENES CHROMOSOMES & CANCER, 2014, 53 (10): : 824 - 832
  • [2] TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia
    Zhang, Ting-Juan
    Zhou, Jing-Dong
    Yang, Dong-Qin
    Wang, Yu-Xin
    Wen, Xiang-Mei
    Guo, Hong
    Yang, Lei
    Lian, Xin-Yue
    Lin, Jiang
    Qian, Jun
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (08) : 5838 - 5846
  • [3] Prevalence and Clinical Effect of TET2 Mutations in Cytogenetically Normal Acute Myeloid Leukemia (CN-AML)
    Markus, Birgit
    Thol, Felicitas
    Morgan, Michael A.
    Wagner, Katharina
    Heuser, Michael
    Krauter, Juergen
    Ganser, Arnold
    Damm, Frederik
    BLOOD, 2011, 118 (21) : 629 - 629
  • [4] Landscape of TET2 mutations in acute myeloid leukemia
    Weissmann, S.
    Alpermann, T.
    Grossmann, V.
    Kowarsch, A.
    Nadarajah, N.
    Eder, C.
    Dicker, F.
    Fasan, A.
    Haferlach, C.
    Haferlach, T.
    Kern, W.
    Schnittger, S.
    Kohlmann, A.
    LEUKEMIA, 2012, 26 (05) : 934 - 942
  • [5] Landscape of TET2 mutations in acute myeloid leukemia
    S Weissmann
    T Alpermann
    V Grossmann
    A Kowarsch
    N Nadarajah
    C Eder
    F Dicker
    A Fasan
    C Haferlach
    T Haferlach
    W Kern
    S Schnittger
    A Kohlmann
    Leukemia, 2012, 26 : 934 - 942
  • [6] Cytogenetically normal acute myeloid leukemia
    Buechner, Thomas
    Berdel, Wolfgang E.
    Kienast, Joachim
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (06): : 651 - 651
  • [7] TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML) TET2 exon 2 skipping in AML
    Mohamed, Aminetou Mint
    Balsat, Marie
    Koering, Catherine
    Maucort-Boulch, Delphine
    Boissel, Nicolas
    Payen-Gay, Lea
    Cheok, Meyling
    Mortada, Hussein
    Auboeuf, Didier
    Pinatel, Christiane
    El-Hamri, Mohamed
    Tigaud, Isabelle
    Hayette, Sandrine
    Dumontet, Charles
    Cros, Emeline
    Flandrin-Gresta, Pascale
    Nibourel, Olivier
    Preudhomme, Claude
    Thomas, Xavier
    Nicolini, Franck-Emmanuel
    Solly, Francoise
    Guyotat, Denis
    Campos, Lydia
    Michallet, Mauricette
    Ceraulo, Antony
    Mortreux, Franck
    Wattel, Eric
    LEUKEMIA RESEARCH, 2017, 56 : 21 - 28
  • [8] Molecular prognostic factors in cytogenetically normal acute myeloid leukemia
    Walker, Alison
    Marcucci, Guido
    EXPERT REVIEW OF HEMATOLOGY, 2012, 5 (05) : 547 - 558
  • [9] Molecular Mutations and Their Cooccurrences in Cytogenetically Normal Acute Myeloid Leukemia
    Wang, Mengning
    Yang, Chuanwei
    Zhang, Le
    Schaar, Dale G.
    STEM CELLS INTERNATIONAL, 2017, 2017
  • [10] Molecular Markers in Cytogenetically Normal Elderly Acute Myeloid Leukemia
    Bloomfield, C. D.
    ANNALS OF HEMATOLOGY, 2011, 90 : S34 - S35
12345